Association of a miR-502-Binding Site Single Nucleotide Polymorphism in the 3'-Untranslated Region of SET8 and the TP53 Codon 72 Polymorphism with Cervical Cancer in the Chinese Population

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 16, 2014, Pages 6505-6510

  Yang, Shao Di ^a   Cai, Yan Lin ^b   Jiang, Pei ^a   Li, Wen ^a   Tang, Jian Xin ^a  

^a HUNAN UNIVERSITY OF TECHNOLOGY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Cervical cancer; MicroRNA; Polymorphism; SET8; Synergism; TP53

Indexed keywords

3' UNTRANSLATED REGION; HISTONE LYSINE METHYLTRANSFERASE; MICRORNA; MIRN502 MICRORNA, HUMAN; PROTEIN P53; SETD8 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ASIAN CONTINENTAL ANCESTRY GROUP; BINDING SITE; CHINA; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; MIDDLE AGED; NUCLEOTIDE SEQUENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX TUMOR;

3' UNTRANSLATED REGIONS; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; BINDING SITES; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; MICRORNAS; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 84906834006     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.16.6505     Document Type: Article

References (36)

1. Abbas T, Shibata E, Park J, et al, (2010). CRL4 (Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation. Mol Cell, 40, 9-21.
2. Akinyemiju TF (2012). Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the world health survey. PLoS One, 7, e48834.
3. Beck DB, Oda H, Shen SS, Reinberg D (2012). PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation and transcription. Genes & Dev, 26, 325-37.
4. Bhattacharya P, Sengupta S (2005). Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women. Gynecol Oncol, 99, 176-82.
5. Centore RC, Havens CG, Manning AL, et al, (2010). CRL4 (Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase. Mol Cell, 40, 22-33.
6. Clotti M, Colrtti A, Giuliani L, et al, (2006). The p53 codon 72 arg/arg homozygous women in central Italy are at increased risl for HPV infections. Anticancer Res, 26, 3745-8.
7. Congdon LM, Houstion SI, Veerappan CS, et al, (2010). PRSet7-mediated monomethylation of histone H4 lysine 20 at specific genomic regions induces transcriptional repression. J Cell Biochem, 110, 609-19.
8. Ding C, Li R, Peng J, Li S, Guo Z (2012). A polymorphism at the miR-502 binding site in the 3'untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer. Exp Ther Med, 3, 689-92.
9. Elkhair MM, Ennaji MM, El Kebbaj R, et al, (2010). P53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women. Med Oncol, 27, 861-6.
10. Giacomini KM, Brett CM, Aitman RB, et al, (2007). The pharmacogenetics research network: from SNP discovery to clinical drug response. Clinical Pharmacology & Therapeutics, 81, 328-45.
11. Ginsberg GM, Lauer JA, Zelle S, Baeten S, Baltussen R (2012). Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ, 344, e614.
12. Gocze K, Gombos K, Juhasz K, et al, (2013). Unique microRNA expression profiles in cervical cancer. Anticancer Res, 33, 2561-7.
13. Govan VA, Loubser S, Saleh D, Hoffman M, Williamson AL (2007). No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency. Int J Immunogenet, 34, 213-7.
14. Guo Z, Wu C, Wang X, et al, (2012). A polymorphism at the miR-[502] binding site in the 3'-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome. Int J Cancer, 131, 1318-22.
15. Habbous S, Pang V, Eng L, et al, (2012). P53 Arg72Pro polymorphism, HPV statues and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis. Clin Cancer Res, 18, 6407-15.
16. Hollstein M, Hainaut P (2010). Massively regulated genes: the example of TP53. J Pathology, 220, 164-73.
17. Houston SI, Mcmanus KJ, Adams MM, et al, (2008). Catalytic function of the PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for mitotic entry and genomic stability. J Biol Chem, 283, 19478-88.
18. Jiang P, Liu J, Zeng X, Li W, Tang J (2010). Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women. Cancer Genetics and Cytogenetics, 197, 174-8. Jøgensen S, Elvers I, Trelle MB, et al (2007). The histone methyltransferase SET8 is required for S-phase Progression. J Cell Biol, 179, 1337-45.
19. Jøgensen S, Elvers I, Trelle MB, et al (2007). The histone methyltransferase SET8 is required for S-phase Progression. J Cell Biol, 179, 1337-45.
20. Kim T, Lee SY, Rho JH, et al, (2009). Mutant p53 (G199V) gains antiapoptotic function through signal transducer and activator of transcription 3 in anaplastic thyroid cancer cells. Mol Cancer Res, 7, 1645-54.
21. Li Z, Nie F, Wang S, Li L (2011). Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation. Proc Natl Acad Sci USA, 108, 3116-23.
22. Moore EE, Wark JD, Hopper JL, et al (2012). The role of genetic and environmental factors on risk of cervical cancer: a review of classical twin studies. Twin Res Hum Genet, 15, 79-86.
23. Nicoloso MS, Sun H, Spizzo R, et al (2010). Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res, 70, 2789-98.
24. Oda H, Okamoto I, Murphy N, et al (2009). Monomethylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse development. Mol Cell Biol, 29, 2278-95.
25. Roh JW, Kim BK, Lee CH, et al, (2010). P53 codon 72 and [21p] codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women. Oncol Res, 18, 453-9.
26. Setteetham-Ishida W, Kanjanavirojkul N, Kularbkaew C, Ishida T (2005). Human papillomavirus genotypes and the p53 codon 72 polymorphism in cervical cancer of Northeastern Thailand. Microbiol Immunol, 49, 417-21.
27. Shi X, Kachirskaia I, Yamaguchi H, et al, (2007). Modulation of [53p] function by SET8-mediated methylation at lysine 382. Mol Cell, 27, 636-46.
28. Shuai HL, Luo X, Yan RL, et al, (2012). XRCC1 polymorphisms are associated with cervical cancer risk and response to chemotherapy: a systematic review and meta-analysis. Asian Pac J Cancer Prev, 13, 6423-7.
29. Singhal P, Hussain S, Thakur N, et al, (2013). Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma. DNA Cell Biol, 32, 19-27.
30. Sitakan N, Wannapa SI, Chamsai P, et al, (2013). Human papillomavirus genotypes and cervical cancer in Northeast Thailand. APJCP, 14, 6961-4.
31. Song F, Zheng H, Liu B, et al, (2009). An miR-502-binding site single-nucleotide polymorphism in the 3'-Untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin Cancer Res, 15, 6292-300.
32. Storey A, Thomas M, Kalita A, et al, (1998). Role od a p53 polymorphism in the development of human papillomavirusassciated cancer. Nature, 393, 229-34.
33. Tardat M, Murr R, Herceg Z, Sardet C, Julien E (2007). PR-Set7-dependent lysine methylation ensures genome replication and stability through S phase. J Cell Biol, 179, 1413-26.
34. Wang C, Guo Z, Li Y, Kang S (2012). A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the risk of epithelial ovarian cancer. Cancer Genet, 205, 373-6.
35. Xu J, Yin Z, Gao W, et al, (2013). Genetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population. PLoS ONE, 8, e77024.
36. Zhou X, Gu Y, Zhang SL (2012). Association between p53 codon [72] polymorphism and cervical cancer risk among Asians: a huge review and messta-analysis. Asian Pac J Ca ncer Prev, 13, 4909-14.